Lamina dura thickening in patients on antiresorptive therapy as a radiographic risk indicator of MRONJ: a retrospective longitudinal cohort study
Clicks: 1
ID: 314239
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #36 of 46 articles by views in dentomaxillofacial radiology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AIMS: This study investigated whether antiresorptive drug (ARD) therapy is associated with lamina dura (LD) thickening, defined as a radiographic increase in the thickness of the normally thin, radiopaque cortical line surrounding the tooth root. It further evaluated whether LD thickening serves as a radiographic marker and risk indicator for medication-related osteonecrosis of the jaw (MRONJ). METHODS: Panoramic radiographs from 65 ARD-treated patients (University Hospital Leuven) and 65 age- and sex-matched controls were analysed. Inclusion criteria were prior oncological diagnosis, high-dose intravenous ARD, and radiographs before and after therapy. Three blinded oral and maxillofacial radiologists categorised LD appearance into four grades: (0) not/barely visible, (1) normal, (2) mild thickening, (3) marked thickening. Group differences and longitudinal changes were evaluated using appropriate non-parametric and time-to-event analyses. RESULTS: Among 130 participants, LD-thickness remained stable in controls but increased in ARD-treated patients (p < 0.001). Within the ARD group, LD thickening changed over time (p < 0.001): 30.6% showed no change, 55.4% developed mild thickening, and 13.8% marked thickening. Controls showed minimal change (p = 0.011), with 9.2% developing mild thickening. Kaplan-Meier analysis estimated a median time to LD thickening of 27 months, with a higher thickening probability in ARD-treated patients than controls (p < 0.001). LD thickening was not directly associated with MRONJ (p = 0.39). CONCLUSION: LD thickening is strongly associated with long-term ARD exposure and shows progressive changes. Although not directly associated with MRONJ in this cohort, it may still represent a potential risk indicator; warranting confirmation in further studies.
| Reference Key |
openalex_W7161786624
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sonya Radi, Samy El Bachaoui, Ilya Tsiklin, Constanza Pastenes, Hanne De Backer, Ruxandra Coropciuc, Tim Van den Wyngaert, Benoit Beuselinck, Reinhilde Jacobs |
| Journal | dentomaxillofacial radiology |
| Year | 2026 |
| DOI |
10.1093/dmfr/twag029
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.